Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer

By                            

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 83-89

Spandidos Publications

Access to resources Recommend Favorite

Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 775-780

Science Publishers

Access to resources Recommend Favorite

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer

By                

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 663-668

Spandidos Publications

Access to resources Recommend Favorite

Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1117-1122

Science Publishers

Access to resources Recommend Favorite

Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 257-264

Spandidos Publications

Access to resources Recommend Favorite